Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized clinical trial - O’Brien, M P; Forleo-Neto, E; Sarkar, N (JAMA, 2022)
et al.